Casein Kinase
Casein Kinases (CKs) are serine/threonine-selective enzymes that function as regulators of signal transduction pathways in most eukaryotic cell types.
Targets for Casein Kinase
Products for Casein Kinase
- Cat.No. Product Name Information
-
GC62735
(E/Z)-GO289
(E/Z)-GO289 is a potent and selective casein kinase 2 (CK2) inhibitor (IC50=7 nM). (E/Z)-GO289 strongly lengthens circadian period. (E/Z)-GO289 exhibits cell type–dependent inhibition of cancer cell growth that correlated with cellular clock function.
-
GC46351
(S)-CR8
An inhibitor of cyclin-dependent kinases
-
GC60037
A-3 hydrochloride
A-3 hydrochloride is a potent, cell-permeable, reversible, ATP-competitive non-selective antagonist of various kinases.
-
GC64638
ALV1
ALV1 is a potent Ikaros and Helios degrader.
-
GC14899
AMG 548
P38α inhibitor,potent and selective
-
GC38518
AMG-548 dihydrochloride
AMG-548 dihydrochloride, an orally active and selective p38α inhibitor (Ki=0.5 nM), shows slightly selective over p38β (Ki=36 nM) and >1000 fold selective against p38γ and p38δ.
-
GC62880
BTX161
BTX161, a Thalidomide analog, is a potent CKIα degrader. BTX161 mediates degradation of CKIα better than Lenalidomide in human AML cells and activates DNA damage response (DDR) and p53, while stabilizing the p53 antagonist MDM2.
-
GC66033
Casein kinase 1δ-IN-1
Casein kinase 1δ-IN-1 (compound 822) is an inhibitor of casein kinase 1 delta (CK1δ), exhibits inhibition of greater than 5%. Casein kinase 1δ-IN-1 can be used for neurodegenerative disorders such as Alzheimer's disease research.
-
GC67775
Casein kinase 1δ-IN-3
-
GC71277
Casein kinase 1δ-IN-6
Casein kinase 1δ-IN-6 is a potent and selective protein kinase CK-1δ inhibitor with an IC50 of 23 nM.
-
GC72207
Casein Kinase 2 Substrate Peptide
Casein Kinase 2 Substrate Peptide is a common CK2 substrate peptide.
-
GC30276
Casein Kinase II Inhibitor IV
Casein Kinase II Inhibitor IV is a potent, ATP-competitive of casein kinase II inhibitor with an IC50 of 9 nM.
-
GC34356
Casein Kinase II Inhibitor IV Hydrochloride
Casein Kinase II Inhibitor IV Hydrochloride is a small-molecule inducer of epidermal keratinocytedifferentiation.
-
GC62442
Casein Kinase inhibitor A51
Casein Kinase inhibitor A51 is a potent and orally active casein kinase 1α (CK1α) inhibitor. Casein Kinase inhibitor A51 induces leukemia cell apoptosis, and has potent anti-leukemic activities.
-
GC63463
Casein Kinase inhibitor A86
Casein Kinase inhibitor A86 is a potent and orally active casein kinase 1α (CK1α) inhibitor. Casein Kinase inhibitor A86 also inhibits of CDK7 (TFIIH) and CDK9 (P-TEFb). Casein Kinase inhibitor A861 induces leukemia cell apoptosis, and has potent anti-leukemic activities.
-
GC40515
CAY10577
Casein kinase 2 (CK2) is a serine/threonine-selective protein kinase involved in many signal transduction pathways.
-
GC43177
CAY10578
Casein Kinase 2 (CK2) is a constitutive protein kinase involved in many signal transduction pathways.
-
GC34536
CK1-IN-1
CK1-IN-1 is a casein kinase 1 (CK1) inhibitor extracted from patent WO2015119579A1, compound 1c, has IC50s of 15 nM, 16 nM, 73 nM for CK1δ, and CK1ε, p38σ MAPK, respectively.
-
GC73500
CK1-IN-2
CK1-IN-2 (compound Nr.4) is a potent CK1 inhibitor with an IC50 values of 123, 19.8, 26.8, 74.3 nM for CK1a, CK1d, CK1e, p38a, respectively.
-
GC62337
CK2 inhibitor 2
CK2 inhibitor 2 is a potent, selective and orally active inhibitor of CK2, with an IC50 of 0.66 nM. CK2 inhibitor 2 shows high selectivity for Clk2 (IC50=32.69 nM)/CK2. CK2 inhibitor 2 exhibits favorable antiproliferative and antitumor activity.
-
GC39485
CK2/ERK8-IN-1
A dual inhibitor of CK2 and ERK8
-
GC38755
CKI-7
CKI-7 is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC50 of 6 μM and a Ki of 8.5 μM. CKI-7 is a selective Cdc7 kinase inhibitor. CKI-7 also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1). CKI-7 has a much weaker effect on casein kinase II and other protein kinases.
-
GC13037
CX-4945 (Silmitasertib)
CX 4945;CX4945
CX-4945 (Silmitasertib) (CX-4945) is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'. -
GC11325
CX-4945 sodium salt
CX-4945 sodium salt
CX-4945 sodium salt is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'. -
GC13202
D4476
Casein Kinase I Inhibitor
Inhibitor of CK1 and ALK5 -
GC73741
DEG-77
DEG-77, a PROTAC based IKZF2 and CK1α degrader, possesses suitable pharmacokinetic properties, solubility, and selectivity for in vivo studies (t1/2=8h).
-
GC17837
DMAT
Casein Kinase II Inhibitor II, 2-Dimethylamino-4,5,6,7-tetrabromobenzimidazole
A cell-permeable inhibitor of CK2 -
GC15548
Ellagic acid
Gallogen, Lagistase, TBBD
Casein kinase 2 (CK2) inhibitor -
GC16044
Emodin
Archin, Frangulic Acid, NSC 408120, NSC 622947, Schuttgelb
Natural CK2 inhibitor and ER agonist -
GC43618
Epiblastin A
Epiblastin A is an ATP-competitive inhibitor of the casein kinase 1 (CK1) isoforms α, δ, and ε (IC50s = 8.9, 0.5, and 4.7 μM, respectively).
-
GC64005
FPFT-2216
FPFT-2216, a “molecular glue” compound, degrades phosphodiesterase 6D (PDE6D), zinc finger transcription factors Ikaros (IKZF1), Aiolos (IKZF3), and casein kinase 1α (CK1α).
-
GC39266
Hematein
Hematein is a oxidation product of hematoxylin acted as a dye. Hematein is an allosteric casein kinase II inhibitor with an IC50 of 0.74 μM. Hematein inhibits Akt/PKB Ser129 phosphorylation, the Wnt/TCF pathway and increases apoptosis in lung cancer cells.
-
GC14503
IC261
SU5607
CK1 inhibitor -
GC52175
IQA
CGP 029482
-
GC16454
IWP-2
IWP 2
IWP-2 is a specific inhibitor of Porcupine enzyme in the Wnt signaling pathway, with an IC50 value of 27 nM. -
GC17466
LH846
Casein kinases inhibitor
-
GC34650
Longdaysin
Longdaysin is a inhibitor of the Wnt/β-catenin signaling pathway, which exerts antitumor effect through blocking CK1δ/ε-dependent Wnt signaling. Longdaysin inhibits CK1α, CK1δ, CDK7, and ERK2 with IC50s of? 5.6 ?M, 8.8 ?M, 29 ?M, and 52 ?M, respectively.
-
GC50009
LY 294002 hydrochloride
Prototypical PI 3-kinase inhibitor; also inhibits other kinases
-
GC36708
NCC007
NCC007 is a dual casein kinase Iα (CKIα) and δ (CKIδ) inhibitor with IC50s of 1.8 and 3.6 μM, respectively.
-
GC73707
ON 108600
ON 108600 is a inhibitor for CK2 (Casein Kinase2)/TNIK/DYRK1 , with the IC50s for DYRK1A/DYRKB, DYRK2, CK2α1/CK2α2, and TNIK of 0.016 μm/0.007 μM, 0.028 μM, 0.05 μM/0.005 μM, and 0.005 μM, respectively.
-
GC69633
Orobol
Orobol is a major soy isoflavone with various pharmacological activities, including anti-aging and anti-obesity effects. Orobol inhibits CK1ε, VEGFR2, MAP4K5, MNK1, MUSK, TOPK and TNIK (IC50=1.24-4.45 μM). Orobol also inhibits PI3K subtypes (for PI3K α/β/γ/K/δ, IC50=3.46-5.27 μM).
-
GC44612
PF-4800567
PF-4800567 is a selective inhibitor of casein kinase 1ε (CK1ε; IC50 = 32 nM) with greater than 20-fold selectivity over CK1δ.
-
GC36885
PF-5006739
PF-5006739 is a potent and selective inhibitor of CK1δ/ε with IC50s of 3.9 nM and 17.0 nM, respectively.
-
GC10556
PF-670462
An inhibitor of the CK1 isoforms CK1ε and CK1δ
-
GC38578
PI-828
A PI3K inhibitor
-
GC64382
SGC-CK2-1
SGC-CK2-1 is a highly potent, ATP-competitive, and cell-active CK2 chemical probe with exclusive selectivity for both human CK2 isoforms, with IC50s of 36 and 16 nM for CK2α and CK2α′respectively in the nanoBRET assay.
-
GC73870
SJ3149
SJ3149 is a selective and potent in vitro and in vivo degrader of CK1α protein with broad antiproliferative activity.
-
GC19336
SR-3029
SR-3029 is a potent and ATP competitive CK1δ and CK1ε inhibitor, with IC50s of 44 nM and 260 nM, respectively, and Kis of 97 nM for both kinases.
-
GC72856
SRPIN803
SRPIN803 is a potent CK2 and SRPK1 dual inhibitor, with IC50s of 203 nM and 2.4 μM, respectively.
-
GC13825
TA 01
CK1ε, CK1δ,and p38α inhibitor
-
GC12181
TBB
NSC 231634, Tetrabromobenzotriazole
An inhibitor of CK2 -
GC64131
TMX-4116
TMX-4116 is a casein kinase 1α (CK1α) degrader. TMX-4116 shows the degradation preference for CK1α with DC50s less than 200 nM in MOLT4, Jurkat, and MM.1S cells. TMX-4116 can be used for the research of multiple myeloma.
-
GC10649
TTP 22
TTP22;TTP-22
A CK2 inhibitor